The current valuation score of Mirum Pharmaceuticals Inc is 9.65, ranking 10 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is -7.88, which is -39.27% below the recent high of -4.79 and -2900.76% above the recent low of -236.52.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.